Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00400868
Other study ID # niedk_EK444_
Secondary ID
Status Completed
Phase N/A
First received November 15, 2006
Last updated February 23, 2010
Start date July 2006
Est. completion date September 2009

Study information

Verified date February 2010
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

The purpose of the study is to compare the short- and long-term effectiveness of an individualized, resource-oriented joint protection intervention with the standard, problem-oriented joint protection intervention for patients with rheumatoid arthritis.


Description:

Joint Protection (JP)is an important intervention in the management of people with arthritis. Altering working methods (e.g. use of proximal joints, dynamic activities), energy conservation (balance between activity and rest) and using assistive devices should place less strain on joint structures weakened by the disease process. These strategies ought to decrease pain and stress on joints, improve function, and facilitate maintaining social roles.

The effectiveness of JP has been evaluated in a number of studies, all in a group setting. JP has beneficial short-term effects on pain and function in patients with established RA and moderate functional problems. Using assistive devices reduces pain during task performance in comparison to normal methods and altering working methods significantly reduces difficulties in activities of daily living (ADL). However this generally does not result in significant behavioral changes and a long-term impact on reducing pain and maintaining function may only be reached if JP is taught using behavioral education methods. Additionally, adherence of RA patients to different interventions is generally modest, which may well determine the effectiveness of any given intervention, especially in the long-term.

All previous studies were carried out in group settings, however, in Switzerland, standard JP education is provided on a one-to-one basis and an individualized education is assumed to be a promising approach.

This clinical trial aims to test the hypothesis that an individualized, resource-oriented JP education in RA patients leads to a better therapy success in the short and long-term, compared to problem-oriented standard JP education in terms of joint protection behavior. Secondary outcome parameters are self-perception, general and specific self-efficacy and general and health-related quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date September 2009
Est. primary completion date February 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Diagnosis of RA according to ACR Guidelines (1988)

- Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation

- Referred to OT for a Joint Protection intervention program

- Willingness to comply with the randomly assigned treatment and informed consent

- Functional Class: 2 to 4

- German speaking/understanding/reading

- Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation

Exclusion Criteria:

- Functional class 1 (anticipated self-exclusion, as patients in class 1 will not be referred to JP).

- Severe finger, hand, elbow or shoulder deformities

- Insufficient ability to understand, speak and read the German language

- Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
psycho-educational Joint protection education
individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later

Locations

Country Name City State
Switzerland University Hospital Bern
Switzerland Rehabilitation Clinic Valens
Switzerland Schulthess Klinik Zurich
Switzerland University Hospital Zurich

Sponsors (4)

Lead Sponsor Collaborator
University of Zurich Gertrude und Wolfgang Schrader-Dislich Stiftung, Zurich, Switzerland, Swiss Ligue Against Rheumatism, Zurich, Switzerland, Zürcher Rheumastifung , Zurich, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary joint protection behavior before/after intervention, 3,6,12 months follow up No
Secondary General quality of life before intervention, 3,6,12 months follow up No
Secondary Health related quality of life / physical functional ability before intervention, 6,12 months follow up No
Secondary Self-Illness Separation SIS, derived from the PRISM (intervention group) before/during/after intervention, 3,6,12 months follow up No
Secondary Goals achievement (intervention group) during/after intervention, 3,6,12 months follow up No
Secondary Hand impairment status, including pain before/during/after intervention, 3,6,12 months follow up No
Secondary Arthritis self-efficacy and JP-specific self-efficacy before/after intervention, 3,6,12 months follow up No
Secondary Self-perceived disease activity before intervention, 12 months follow up No
Secondary Clinical data before intervention, 3, 12 months follow up No
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4